European registry aims to improve care for pancreatic enzyme deficiency

NCT ID NCT05450627

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study creates a registry of adults with pancreatic exocrine insufficiency (PEI), a condition where the pancreas does not produce enough enzymes to digest food properly. Researchers at eight specialist centers across Europe will track how doctors prescribe pancreatic enzyme replacement therapy (PERT) in routine practice. The goal is to understand the doses needed to relieve symptoms and improve nutrition, without imposing any specific tests or treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Pancreatic enzyme replacement therapy
What this could lead to
This registry could help doctors better understand how to manage pancreatic enzyme insufficiency, potentially improving treatment guidelines and patient outcomes.
What could go wrong
As an observational registry, it does not test a new treatment or prove cause and effect. Results may vary across different causes of the condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXOCRINE PANCREATIC INSUFFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Clinico Universitario de Santiago

    Santiago de Compostela, A Coruña, 15706, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.